AAP
MEDP icon

Arax Advisory Partners’s Medpace MEDP Stock Holding History

Arax Advisory Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.31M Buy
6,259
+5,778
+1,201% +$2.67M 0.02% 622
2026
Q1 		$230K Buy
481
+326
+210% +$167K 0.01% 1012
2025
Q4 		$87.1K Sell
155
-14,945
-99% -$8.48M ﹤0.01% 1388
2025
Q3 		$7.76M Buy
15,100
+15,037
+23,868% +$6.57M 0.11% 143
2025
Q2 		$19.8K Sell
63
-19
-23% -$5.7K ﹤0.01% 1671
2025
Q1 		$25K Buy
82
+59
+257% +$19.8K ﹤0.01% 1212
2024
Q4 		$7.64K Sell
23
-181
-89% -$61.4K ﹤0.01% 1581
2024
Q3 		$68.1K Sell
204
-2
-1% -$760 0.01% 606
2024
Q2 		$84.8K Buy
206
+202
+5,050% +$80K 0.01% 501
2024
Q1 		$1.62K Sell
4
-2
-33% -$703 ﹤0.01% 1076
2023
Q4 		$1.84K Hold
6
– – ﹤0.01% 1030
2023
Q3 		$1.45K Hold
6
– – ﹤0.01% 1064
2023
Q2 		$1.44K Hold
6
– – ﹤0.01% 1044
2023
Q1 		$1.13K Hold
6
– – ﹤0.01% 1084
2022
Q4 		$1.27K Hold
6
– – ﹤0.01% 1022
2022
Q3 		$1K Sell
6
-2
-25% -$319 ﹤0.01% 1110
2022
Q2 		$1K Hold
8
– – ﹤0.01% 1072
2022
Q1 		$1K Hold
8
– – ﹤0.01% 1056
2021
Q4 		$2K Buy
+8
New +$1.68K ﹤0.01% 898

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Arax Advisory Partners's MEDP Position: Q2 2026 in Review

Arax Advisory Partners increased its Medpace (MEDP) stake by 1,201% in Q2 2026, buying an estimated $2.67M and bringing the position to 6,259 shares worth $3.31M. The position accounts for 0.02% of the portfolio, ranked #622.

Arax Advisory Partners first reported a position in MEDP in Q4 2021 and has held it in 19 quarters since. The position peaked at $7.76M in Q3 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Arax Advisory Partners held 6,259 shares of Medpace worth $3.31M as of Q2 2026.
  • Arax Advisory Partners bought 5,778 Medpace shares in Q2 2026, an estimated $2.67M.
  • Medpace made up 0.02% of Arax Advisory Partners's portfolio in Q2 2026, its #622 holding.
  • Arax Advisory Partners first reported a position in Medpace in Q4 2021 and has held it in 19 quarters since.
  • Arax Advisory Partners's Medpace position peaked at $7.76M in Q3 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.